Investor Login

About

DRI Capital manages private equity funds that purchase royalties from pharmaceutical and biotechnology companies, research institutions, universities, and inventors. DRI is a pioneer and global leader in royalty investing with well over U.S. $3 billion in assets under management.

Approach

DRI Capital's strengths as counterparty in royalty monetization transactions include its:

  • Relationship Oriented Approach
  • Breadth of Knowledge
  • Certainty of Deal Execution
  • Access to Capital

READ MORE